logo
Plus   Neg
Share
Email

Nokia Declares More Than 3,000 5G Patents

Nokia said it declared more than 3,000 patent families as essential for 5G, less than six months after declaring its previous milestone at 2,000 patent declarations.

With the latest declarations, the portfolio of Nokia cellular standard essential patents declared to one or more of the 2G, 3G, 4G and 5G standards spans more than 3,400 patent families, of which more than 3,000 are relevant to 5G standards.

Nokia Bell Labs recently announced a new world record in fiber optics to enable faster and higher capacity 5G networks for the future. Researchers at Nokia Bell Labs set the world record for the highest single carrier bit rate at 1.52 Terabits per second (Tbit/s) over 80 km of standard single mode fiber - the equivalent of simultaneously streaming 1.5 million YouTube videos - and four times the market's previous capabilities of approximately 400 Gigabits per second.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
RELATED NEWS
Follow RTT